Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.
6/19/2018 • Senate
Summary
Synthetic Abuse and Labeling of Toxic Substances Act of 2017 or the SALTS Act
(Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)
Reported to Senate without amendment • 6/19/2018
Topics & Subjects
CBO Cost Estimates (1)
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (18)
Party Breakdown
Sponsor
Cosponsors (17)
Bill Journey
Originated in the Senate
Introduced
January 24, 2017
Committee Review
April 11, 2018
Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law